Moneycontrol
Last Updated : Jan 03, 2018 05:45 PM IST | Source: CNBC-TV18

World Health Organisation endorses Bharat Biotech's Typbar typhoid vaccine

Hyderabad-based Bharat Biotech's Typbar or 'Typhoid Vaccine' gets the pre-qualification nod from the World Health Organisation; opening doors to market the vaccine across 126 countries globally.

CNBC TV18 @moneycontrolcom

Hyderabad-based Bharat Biotech's Typbar or 'Typhoid Vaccine' gets the pre-qualification nod from the World Health Organisation; opening doors to market the vaccine across 126 countries globally. Speaking to CNBC-TV18's Nithya Balakrishnan, Krishna Ella, MD at Bharat Biotech adds that innovation will continue to be the focal point for the company and listing on the bourses will need to wait.

Watch videos for more….
First Published on Jan 3, 2018 05:37 pm

tags #Business

Sections
Follow us on
Available On